Article Information
History
- April 10, 2020.
Article Versions
- Version 1 (April 4, 2020 - 05:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Tobias Herold, MD1,2,3,4,*,+,
- Vindi Jurinovic, PhD1,5,*,
- Chiara Arnreich1,4,
- Johannes C. Hellmuth, MD1,
- Michael von Bergwelt-Baildon, MD PhD1,3,6,
- Matthias Klein, MD2,7 and
- Tobias Weinberger, MD2,8
- 1Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
- 2Emergency Department, University Hospital, LMU Munich, Munich, Germany
- 3Nine-i Investigator
- 4Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Center for Environmental Health (HMGU), Munich, Germany
- 5Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany
- 6Intensive Care in Hematologic and Oncologic Patients (iCHOP), Cologne, Germany
- 7Department of Neurology, University Hospital, LMU Munich, Munich, Germany
- 8Department of Medicine I, University Hospital, LMU Munich, Munich, Germany
- ↵+Corresponding Author:
Tobias Herold, MD; Marchioninistr. 15; 81377 Munich; Germany; Phone: +49 89 4400-0; FAX: +49 89 4400-74242; Email: tobias.herold{at}med.uni-muenchen.de
↵* Contributed equally
Posted April 10, 2020.
Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients
